PubRank

Benjamin Kim

Author PubWeight™ 34.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A 2002 4.37
2 Pure red-cell aplasia and epoetin therapy. N Engl J Med 2004 3.49
3 Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica 2007 1.87
4 Are electronic health records ready for genomic medicine? Genet Med 2009 1.82
5 Breast implant-associated anaplastic large cell lymphoma: a systematic review. Plast Reconstr Surg 2015 1.80
6 Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke 2004 1.78
7 Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst 2011 1.71
8 Clinical features predicting the detection of abnormalities by double balloon endoscopy in patients with suspected small bowel bleeding. J Gastroenterol Hepatol 2007 1.46
9 Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood 2005 1.30
10 Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer. J Oncol Pract 2011 1.21
11 Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis 2007 1.14
12 Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood 2005 1.12
13 Visceral obesity as a risk factor for colorectal neoplasm. J Gastroenterol Hepatol 2007 1.10
14 Complications of endovascular repair of high-risk and emergent descending thoracic aortic aneurysms and dissections. J Vasc Surg 2004 1.00
15 Optobiology: optical control of biological processes via protein engineering. Biochem Soc Trans 2013 0.97
16 Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol 2007 0.97
17 Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug. Nanomedicine (Lond) 2012 0.91
18 Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. J Oncol Pract 2012 0.87
19 Preoperative breast MRI in early-stage breast cancer. Breast Cancer Res Treat 2012 0.83
20 A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy. Nanomedicine (Lond) 2015 0.79
21 Facility characteristics and quality of lung cancer care in an integrated health care system. J Thorac Oncol 2014 0.78
22 Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome. Am J Manag Care 2012 0.78
23 A brief account of nanoparticle contrast agents for photoacoustic imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013 0.78
24 Rapid synthesis of near infrared polymeric micelles for real-time sentinel lymph node imaging. Adv Healthc Mater 2012 0.77
25 Late-onset type II endoleaks and the incidence of secondary intervention. Ann Vasc Surg 2004 0.77
26 Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy. J Natl Cancer Inst 2011 0.75
27 Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report. Transfusion 2013 0.75
28 Not a textbook case. J Hosp Med 2015 0.75
29 Clinical problem-solving. The essential element. N Engl J Med 2013 0.75